Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olivia Orozco

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biochemical and Biophysical Research Communications|October 7, 2008
CRIPTO3, a presumed pseudogene, is expressed in cancerChao Sun, Olivia Orozco, Dian L Olson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2018
Mechanistic Insights of an Immunological Adverse Event Induced by an Anti-KIT Antibody Drug Conjugate and Mitigation StrategiesLawrence L'Italien, Olivia Orozco, Tinya Abrams, et al.
Oncogene|May 18, 2005
Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinomaChristian Wechselberger, Luigi Strizzi, Nicholas Kenney, et al.
Biochemistry|February 16, 2005
Glial cell line-derived neurotrophic factor (GDNF) receptor alpha-1 (GFR alpha 1) is highly selective for GDNF versus arteminPaul Carmillo, Lone Dagø, Eric S Day, et al.
The Journal of Clinical Investigation|August 20, 2003
Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivoHeather B Adkins, Caterina Bianco, Susan G Schiffer, et al.
Journal of Medicinal Chemistry|September 29, 2023
Identification of GDC-1971 (RLY-1971), a SHP2 Inhibitor Designed for the Treatment of Solid TumorsAlexander M Taylor, Bret R Williams, Fabrizio Giordanetto, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biochemical and Biophysical Research Communications|October 7, 2008
CRIPTO3, a presumed pseudogene, is expressed in cancerChao Sun, Olivia Orozco, Dian L Olson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2018
Mechanistic Insights of an Immunological Adverse Event Induced by an Anti-KIT Antibody Drug Conjugate and Mitigation StrategiesLawrence L'Italien, Olivia Orozco, Tinya Abrams, et al.
Oncogene|May 18, 2005
Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinomaChristian Wechselberger, Luigi Strizzi, Nicholas Kenney, et al.
Biochemistry|February 16, 2005
Glial cell line-derived neurotrophic factor (GDNF) receptor alpha-1 (GFR alpha 1) is highly selective for GDNF versus arteminPaul Carmillo, Lone Dagø, Eric S Day, et al.
The Journal of Clinical Investigation|August 20, 2003
Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivoHeather B Adkins, Caterina Bianco, Susan G Schiffer, et al.
Journal of Medicinal Chemistry|September 29, 2023
Identification of GDC-1971 (RLY-1971), a SHP2 Inhibitor Designed for the Treatment of Solid TumorsAlexander M Taylor, Bret R Williams, Fabrizio Giordanetto, et al.
Pageof 1